Citius pharmaceuticals to host investor webcast to discuss the acquisition of late phase 3 cancer immunotherapy i/ontak (e7777)

Cranford, n.j., oct. 13, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr) today announced that it will host a webcast on october 20, 2021 at 8:30 a.m.

CTXR Ratings Summary

CTXR Quant Ranking